Quidel Corporation (QDEL) - Total Liabilities
Based on the latest financial reports, Quidel Corporation (QDEL) has total liabilities worth $3.85 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore QDEL cash generation efficiency to assess how effectively this company generates cash.
Quidel Corporation - Total Liabilities Trend (1985–2025)
This chart illustrates how Quidel Corporation's total liabilities have evolved over time, based on quarterly financial data. Check Quidel Corporation asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quidel Corporation Competitors by Total Liabilities
The table below lists competitors of Quidel Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shandong Longhua New Material Co. Ltd.
SHE:301149
|
China | CN¥1.22 Billion |
|
Shenyu Communication Technology Inc
SHE:300563
|
China | CN¥355.83 Million |
|
Imperial Metals Corporation
TO:III
|
Canada | CA$766.00 Million |
|
Gryphon Capital Income Trust
AU:GCI
|
Australia | AU$7.51 Million |
|
Shilpa Medicare Limited
NSE:SHILPAMED
|
India | Rs10.57 Billion |
|
Bergman & Beving AB (publ)
ST:BERG-B
|
Sweden | Skr4.41 Billion |
|
GL Events SA
PA:GLO
|
France | €2.57 Billion |
|
Sinosteel Luonai Materials Technology Co. Ltd. A
SHG:688119
|
China | CN¥2.19 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down Quidel Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Quidel Corporation (QDEL) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.67 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Quidel Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Quidel Corporation (1985–2025)
The table below shows the annual total liabilities of Quidel Corporation from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.85 Billion | +11.91% |
| 2024-12-31 | $3.44 Billion | -3.32% |
| 2023-12-31 | $3.56 Billion | -9.28% |
| 2022-12-31 | $3.92 Billion | +682.67% |
| 2021-12-31 | $501.00 Million | -6.96% |
| 2020-12-31 | $538.46 Million | +53.39% |
| 2019-12-31 | $351.05 Million | -7.81% |
| 2018-12-31 | $380.79 Million | -46.23% |
| 2017-12-31 | $708.15 Million | +277.44% |
| 2016-12-31 | $187.62 Million | -0.11% |
| 2015-12-31 | $187.83 Million | -7.20% |
| 2014-12-31 | $202.40 Million | +324.27% |
| 2013-12-31 | $47.71 Million | +12.73% |
| 2012-12-31 | $42.32 Million | -54.74% |
| 2011-12-31 | $93.51 Million | -8.39% |
| 2010-12-31 | $102.07 Million | +155.85% |
| 2009-12-31 | $39.90 Million | +69.25% |
| 2008-12-31 | $23.57 Million | -9.81% |
| 2007-12-31 | $26.14 Million | +9.94% |
| 2006-12-31 | $23.77 Million | -10.65% |
| 2005-12-31 | $26.61 Million | +18.21% |
| 2004-12-31 | $22.51 Million | -18.07% |
| 2003-12-31 | $27.47 Million | +38.47% |
| 2002-12-31 | $19.84 Million | -9.77% |
| 2001-12-31 | $21.98 Million | -7.34% |
| 2000-12-31 | $23.73 Million | -2.37% |
| 1999-12-31 | $24.30 Million | +207.59% |
| 1998-12-31 | $7.90 Million | -27.52% |
| 1997-12-31 | $10.90 Million | +53.52% |
| 1996-12-31 | $7.10 Million | -6.58% |
| 1995-12-31 | $7.60 Million | -28.30% |
| 1994-12-31 | $10.60 Million | 0.00% |
| 1993-12-31 | $10.60 Million | +2.91% |
| 1992-12-31 | $10.30 Million | +7.29% |
| 1991-12-31 | $9.60 Million | -38.06% |
| 1990-12-31 | $15.50 Million | +142.19% |
| 1989-12-31 | $6.40 Million | +3.23% |
| 1988-12-31 | $6.20 Million | +63.16% |
| 1987-12-31 | $3.80 Million | -30.91% |
| 1986-12-31 | $5.50 Million | +243.75% |
| 1985-12-31 | $1.60 Million | -- |
About Quidel Corporation
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laborator… Read more